CRISPR Gene Editing…The Future is NOW.
The business of gene editing….weird to wrap your head around I know, but that doesn’t mean that it won’t become the new norm in the near future. This revolutionary development in the world of modern medicine has come to be known as CRISPR.
What in the world is CRISPR you might ask?
Well, it stands for Clustered Regularly Interspaced Short Palindromic Repeats….still confused?
Don’t worry, let’s break it down in a way we can all understand.
In short, it is a technology that allows scientists to edit genes in living cells that was originally discovered two decades ago, but with recent technological advancements it has become much more feasible…and PROFITABLE!
Unprecedented applications and potential
Just imagine the applications of this. Imagine a world where we can treat HIV by blocking replication in human cells, a world where we can treat more types of cancer, a world where we can eliminate malaria.
Well you don’t have to imagine any of those things because they ALREADY have been successfully achieved by CRISPR with even more groundbreaking accomplishments to come!
Two BIG biotech companies called Kite Pharmaceuticals and Juno Therapeutics have stepped onto the scene to make incredible headway with the gene editing tech to induce remission in terminal leukemia patients. Private research with CRISPR is also being done at universities across the country from Temple University eliminating HIV from T cells to Wisconsin University developing antibiotics specifically targeting super resistant viruses to the team at the University of Illinois figuring out a way to change individual points within a DNA sequence instead of breaking the strands.
“CRISPR could easily be the most important scientific discovery of the century.”
-Dr. Eric Lander of the Broad Institute at MIT
The CRISPR tech was taken off like a rocket, with extraordinary medical, scientific, and business implications. Newly emerging CRISPR companies and investors are poised to benefit from these recent breakthroughs. Companies utilizing CRISPR technology are being founded, financed, and growing at a monumental rate, and forward thinking investors have already realized substantial and in some cases exponential rewards.
“CRISPR is driving nearly all cutting-edge discoveries in biotech today, from cancer immunotherapy to gene editing”
Mitchell Ng- Thessalus biotech investment fund
The manager of the fund also pointed out the three largest publicly traded CRISPR companies currently on the NASDAQ– Editas Medicine, Crispr Therapeutics, Intellia Therapeutics. Each of these companies tripled in stock price and reached a billion-dollar market capitalizations in the last year alone. This is all the more shocking and slightly confusing because these companies still remain discovery phase ventures which have yet to produce a single treatment for market, garnishing investment expressly through anticipation of their future financial success.
“In my 40+ years of banking I simply have not seen a single technology with the potential to so completely and thoroughly revolutionize the field of medicine, and by extension play such a large role in financing and deal flow for years to come.”- William Kridel, director of the Ferghana Partners
With CRISPR, the power to edit a living genome like an author edits a novel has moved from the realm of science fiction to the realm of reality.
Creating designer babies: It’s not entirely far-fetched.
This Untold story highlights the fact that the more technology advances the more novel medical applications and revolutionary developments will occur in the not so far future. CRISPR technology and the companies that wield it is as a powerful tool for editing genomes will see the investments continuing to flow their way as more discoveries are uncovered. The ability for researchers to easily alter DNA sequences and modify gene function has endless applications including the correction of genetic defects, treatment and prevention of the spread of diseases and improvement of the health of crops for our planet. Keep an eye on the evolution of this technology...the future is NOW.
September 10th, 2018 – Chaz Hermanowski-Untold Business Writer